May 9th, 2012
The federal court overseeing the BP Oil Spill Litigation in New Orleans recently approved a preliminary settlement, which, if finally approved, will reportedly provide in excess of $7.8 billion to pay claims, including those of businesses who submit qualifying economic loss claims. The Gulf Coast Claims Facility (GCCF) will be closing its doors and the Court administered settlement program will begin processing claims as early as June 4, 2012. If your BP claim has been denied by the GCCF, you need... Read More
Posted in
Current Cases, firm-news |
May 9th, 2012
Pendley, Baudin & Coffin Law Firm, LLP is investigating claims of Household Life Insurance Company improperly denying credit disability insurance benefits. Household Life Insurance Company is a subsidiary of HSBC. Household Life Insurance Company primarily sells its credit disability insurance through other subsidiaries of HSBC, including Beneficial Mortgage Company and Mortgage One Corporation d/b/a HFC Mortgage Corporation. The credit disability insurance is routinely sold during a mortgage closing. The credit disability insurance appears to pay the policyholder’s mortgage each month... Read More
Posted in
Current Cases, firm-news |
February 10th, 2012
FIRST EFFEXOR® BIRTH DEFECT COMPLAINT FILED IN PHILADELPHIA Pregnant Mother Ingests Anti-Depressant Drug; Infant Dies PHILADELPHIA – Feb. 9, 2012 – Today, in the Philadelphia Court of Common Pleas, six attorneys from across the country filed what is believed to be the first birth defect case against EFFEXOR®, a popular and common drug used in the treatment of depression. Alleging the death of an Ohio infant was directly related to her mother’s ingestion of EFFEXOR®, the young girl’s parents are... Read More
Posted in
Current Cases |
January 3rd, 2012
Medtronic, manufacturer of Infuse, failed to disclose serious and potentially life-threatening side effects. Infuse is often used in spinal fusion operations in which spinal vertebrae are fused together to reduce back pain; it is a bioengineered material that spurs bone growth. It as reported that in none of the 13 trials funded by Medtronic were any adverse events disclosed. It has been reported that up to 50 percent of patients who received Infuse suffered side effects including infection, pain, cyst... Read More
Posted in
Current Cases |
December 29th, 2011
Pendley, Baudin & Coffin, L.L.P. is currently evaluating Actos (Pioglitazone Hydrochloride) cases for individuals who have been diagnosed with bladder cancer. The Type-2 diabetes drug Actos (also marketed as Duetact, Actoplus and Actoplus Met), which was manufactured, developed and distributed by Takeda Pharmaceuticals, has recently been linked to an increased risk of bladder cancer. In June of 2011, Actos was removed from the markets in France and Germany after studies revealed a potential increased risk of bladder cancer associated with... Read More
Posted in
Current Cases, firm-news |
December 29th, 2011
Rice and crawfish farmers adversely affected by oil barge collision with the gates of Leland Bowman Lock on September 30, 2011. The lock is located on Freshwater Bayou in Vermillion Parish, Louisiana. As a result of the collision, the gates were damaged and the U.S. Army Corps of Engineers has removed the gates and sent them to Morgan City, Louisiana to be repaired. The original purpose of the Leland Bowman Lock structure was to keep saltwater from flowing from Vermillion Bay... Read More
Posted in
Current Cases, firm-news |
October 27th, 2011
Lester Ansardi, a commercial fisherman from coastal Louisiana, has filed a class action lawsuit in the Civil District Court in the State of Louisiana, Parish of Orleans, on behalf of himself and other boat owners who participated in BP’s so-called “Vessels of Opportunity” program. While other class actions have been filed against BP making similar claims, this is the first class action filed against United States Maritime Services, Inc. Continue reading → Read More
Posted in
Current Cases, firm-news |
September 8th, 2011
FDA’s process for approving medical devices is questioned after a promising device to prop open blocked arteries in the brain to prevent disabling or fatal strokes failed. The FDA approved the stent in August of 2005 for high risk patients based on a study with 45 patients. It was intended for high risk patients who had failed medical management. The stent study, a registry study, did not have a control group for comparison. The patients who received the stent had many... Read More
Posted in
Current Cases, firm-news |
August 26th, 2011
PBC has filed a class action case against DuPont, the maker of the Imprelis herbicide which has been reported responsible for serious environmental damage and death of trees particularly evergreens such as Norway Spruce, Eastern White Pine and other shallow root system trees such as Deodora Cedar, Balsam Fir, Willow Trees, Conifer Trees and Poplar Trees. DuPont introduced the Imprelis herbicide in October 2010. Imprelis is used for killing broadleaf weeds like dandelion and clover and is sold to lawn... Read More
Posted in
Current Cases, firm-news |
July 2nd, 2011
Property owners have complained that CertainTeed WeatherBoards fiber cement exterior siding products have caused a number of problems including: shrinking, cracking and warping as well as large gaps between the siding boards. Fiber cement siding is used to cover the exterior wall of a house and is an alternative to vinyl or wood siding. It has been known to be durable and resistant to fire, termites and rot. Other complaints against CertainTeed fiber cement siding have been that it has a... Read More
Posted in
Current Cases, firm-news |
